All News

Canakinumab, a fully human monoclonal antibody, targets interleukin-1β, has anti-inflammatory effects, and is FDA-approved for rheumatologic disorders. Interleukein-1β is a cytokine that drives the interleukin(IL)-6 signaling pathway in inflammatory response.

Pharmacists, and other health care professionals can make a positive impact on health care by encouraging smoking cessation.

Treatment with this peanut immunotherapy consists of 3 phases: Initial Dose Escalation, Up-Dosing, and Maintenance.

The report noted that 8 of the 10 leading causes of death saw lower rates of death in 2018.

Pharmacists can administer the MMR vaccine without a prescription in most states and US territories.

Top news of the day from across the health care landscape.

As technology gains more of a foothold within the health care landscape, pharmacy professionals have an opportunity to harness the power of data and automatization.

The Clinical Advisor program detects potential issues with antibiotic prescribing and sends near real-time alerts to health care providers through means that include mobile devices.

Top news of the week from Specialty Pharmacy Times.

The decision is based on early academic clinical trial data that demonstrated ex-vivo autologous HSC gene therapy being an ideal approach for the treatment of X-CGD, a rare, life-threatening, inherited disease of the immune system.

Which famous actor worked in a pharmacy before getting his big break?

In a tele-briefing Thursday, the CDC also reiterated that the threat to the general public in the US is still low.

Although there are no approved therapies for FSHD, researchers at Fulcrum Therapeutics discovered that inhibition of p38α/β reduced expression of the DUX4 gene in muscle cells derived from patients with FSHD.

Some REMS programs may only require a medication guide to be distributed with each dispense that highlight safety information, such as relevant adverse events and risks associated with taking the product.

DSG3-CAART is designed to target the cause of mucosal pemphigus vulgaris while sparing normal B cell populations that provide immunity from infection.

Top news of the day from across the health care landscape.

Hydromorphone prescription rates may explain the recent increase in cases of infective endocarditis among people who inject drugs.

Iron deficiency anemia is a condition that affects nearly 1 billion people globally,1 in which the blood lacks adequate healthy red blood cells, often leaving those with the condition tired and short of breath.2

The FDA has approved triple-combination extended release tablets to lower blood sugar in adults with type 2 diabetes (T2D), when combined with diet and exercise.

The action marks the first and only OTC topical drug with cannabidiol to receive certification for its listing in the National Drug Code Directory, according to its manufacturer.

A recent study shows that diabetes risk is associated with younger age at onset of obesity, and longer exposure to obesity.

This Tip of the Week focuses on a study to evaluate pharmacy in the context of true patient outcomes, rather than on the structure and process measures often employed in such ratings programs.

Electronic health records and the data created are being used on multiple levels and continue to be a driving force for improving care and lowering health care costs.

Top news of the day from across the health care landscape.

A combination therapy may counter the resistance to human epidermal growth factor receptor 2 inhibitor neratinib in patients with breast, ovarian, lung, or other cancers.

Research may help to develop usable hematopoietic stem cells that could regrow a patient with leukemia’s blood system after chemotherapy and irradiation.

The nationwide continuing education conference series will share the latest clinical data while exploring best practices and management strategies for patients with chronic illnesses.

Specialty pharmacists are well positioned to manage the opioid epidemic because they are in regular contact with their patients who trust them.

Dupilumab has been granted priority review as an add-on maintenance treatment for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies.

The virus, first seen in Wuhan, China, is characterized by mild to severe respiratory illness, including fever, cough, and shortness of breath.